InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,976.97
(
-1.13%
)
US TECH 100
21,168.80
(
0.43%
)
Dow Jones
42,197.79
(
-1.79%
)
Brent Oil
73.18
(
-2.25%
)
Bitcoin
107,168.00
(
1.52%
)
Post# of 17
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TechandBio

Send PM Follow Ignore
Followers 15
Posts 714
Boards Moderated 0
Alias Born 08/12/2022

TechandBio

Re: None

Tuesday, 09/24/2024 6:45:07 PM

Tuesday, September 24, 2024 6:45:07 PM

Post# of 17
IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate
https://www.prnewswire.com/news-releases/icecures-ice3-5-year-trial-results-published-in-the-peer-reviewed-annals-of-surgical-oncology-journal-prosense-cryoablation-without-excision-for-early-stage-low-risk-breast-cancer-demonstrates-96-3-recurrence-free-rate-302256863.html

$ICCM
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up